PGI21 HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MILD-TO-MODERATE ULCERATIVE COLITIS BEFORE AND AFTER 8 WEEKS' TREATMENT WITH MULTI-MATRIX MESALAMINE: COMPARISON WITH 2009 GENERAL POPULATION NORMS IN THE UNITED STATES [PDF]
Aaron Yarlas, L. Yen, P. Hodgkins
openalex +1 more source
Complementary medicines and ginseng for inflammatory bowel disease-rooted in science, but will it bear fruit? [PDF]
Schildkraut T+4 more
europepmc +1 more source
Tofacitinib in active ulcerative colitis [PDF]
COTTONE, Mario, Orlando A, Papi C.
core +1 more source
Exam 1: Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease [PDF]
openalex +1 more source
Comparison of 1-Year Clinical Course in Patients With Newly Diagnosed Inflammatory Bowel Disease Between Vietnam and Korea: A Multinational, Multicenter Retrospective Cohort Study. [PDF]
Dang LM+12 more
europepmc +1 more source
Editorial: Recent advances and new biomarkers in ulcerative colitis, volume II. [PDF]
Velikova T, Xue X.
europepmc +1 more source
Medical, Endoscopic, and Surgical Treatments for Rectal Cuffitis in IBD Patients with an Ileal Pouch-Anal Anastomosis: A Narrative Review. [PDF]
Powers JC+8 more
europepmc +1 more source
Asymptomatic presentation of mesalamine-induced lung injury in an adolescent with Crohn disease
R. Cilloniz+2 more
openalex +2 more sources
Preparation of magnetic microspheres of mesalamine by phase separation emulsion polymerisation technique [PDF]
Satinder Kakar, Ramandeep Singh
openalex +1 more source
Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study. [PDF]
Alarfaj SJ+8 more
europepmc +1 more source